PhoreMost is a new-model drug discovery company based in Cambridge, UK.
PhoreMost has raised $12.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
PhoreMost's investors include XtalPi, Amadeus Capital Partners, Business Growth Fund, Parkwalk Advisors, Morningside.
PhoreMost is headquartered in Cambridge, United Kingdom.
PhoreMost is a new-model drug discovery company based in Cambridge, UK.
PhoreMost is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhoreMost — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/phoremost. Accessed September 14, 2026.
VCBacked. (2024). PhoreMost — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/phoremost
{{cite web |title=PhoreMost — Funding & Investors |url=https://www.vcbacked.co/company/phoremost |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated